Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts. Show more

PO Box 30, Winchester, MA, 01890, United States

Biotechnology

Healthcare

Market Cap

7.429M

52 Wk Range

$0.54 - $1.96

Previous Close

$0.63

Open

$0.63

Volume

6,549

Day Range

$0.60 - $0.63

Enterprise Value

-11.44M

Cash

14.67M

Avg Qtr Burn

-923K

Insider Ownership

21.40%

Institutional Own.

65.56%

Qtr Updated

12/31/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SYNB1353 Details Homocystinuria	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SYNB8802 Details Primary hyperoxaluria	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SYNB1891 Details Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Labafenogene marselecobac (previously SYNB1934) Details Phenylketonuria	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.